# BTIG

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/btig
Canonical HTML page: https://getbiobrief.com/entity/btig

## Recent coverage (1 stories)

### Abbott Beats Q2 with $12.59B Revenue, Analysts Raise PT to $134; UNH Also Surges
2026-07-25 20:28:16 · Sentiment: Bullish · Impact: 7/10 · Sources: 1

Abbott Laboratories reported Q2 revenue of $12.59 billion (+13% YoY), beating estimates and raising its full-year EPS guidance. Analysts hiked price targets in response, with BTIG going to $134, reflecting confidence in its diversified healthcare portfolio and pipeline. UnitedHealth also delivered a massive EPS beat, but Abbott’s medtech and diagnostics momentum carries particular relevance for the biopharma sector.
Full story: https://getbiobrief.com/story/abbott-unh-q2-2026-beat-analyst-target-hikes-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.